With outlets in the United States, France and Germany, Quantel is pursuing its development policy by acquiring additional technologies.

• In 1993, Quantel created a new subsidiary, BVI, which was a shareholder in Biovision, a company specialising in ophthalmological lasers and Ultrasound systems. BVI went on to become Quantel Medical.
  This acquisition united Quantel’s fundamental expertise in laser technology with Biovision’s expertise in the field of ophthalmology. This synergy gave rise to Quantel Medical, world leader in ocular Ultrasound systems and laser photocoagulation.
• In 2004, C2J Electronique, Quantel Medical’s long-term supplier, joined the Quantel Group. This merger served to extend the Group’s technological platform to include electronics, computer science and image processing, thus providing the basis of excellence that underpins Quantel Medical’s high standing in the field of Ultrasound and laser technology.
• In 2007, the Quantel Group took over WaveLight Aesthetic GmbH, which then became Quantel Derma. Quantel Derma is now responsible for Group business in the Dermatology and Aesthetics areas, and currently boasts the world’s largest range of equipment in these fields.

The Group recently extended its knowledge base to include new business areas, i.e., continuous fiber lasers and laser diodes.

Quantel’s innovation and quality strategy has driven the Group’s growth upward by a regular 25% a year over the last ten years. The Group’s customers and partners actively participate in pushing this development forward.

Through its subsidiaries Quantel USA and Quantel Medical Inc., the Quantel Group boasts a solid industrial base in the United States. The Group has successfully expanded onto the international scene. Today, the Quantel network counts over 110 distributors worldwide through a partnership strategy based on trust.